{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:25:32Z","timestamp":1707524732115},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,3]]},"DOI":"10.7759\/cureus.28738","type":"journal-article","created":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T15:06:45Z","timestamp":1662217605000},"source":"Crossref","is-referenced-by-count":0,"title":["Primary Anaplastic Lymphoma Kinase (ALK)-Negative Anaplastic Large Cell Lymphoma (ALCL) Presenting as Perforation Peritonitis: A Case Report and Management Principles"],"prefix":"10.7759","author":[{"given":"Vivek","family":"Sanker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azeem","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maanasi","family":"Pranala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaithra","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varghese","family":"Tharakan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V66.4.848.848","article-title":"The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells","volume":"66","author":"Stein H","year":"1985","unstructured":"Stein H, Mason DY, Gerdes J, et al.. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 1985, 66:848-58. 10.1182\/blood.V66.4.848.848","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1586\/14737140.9.3.331","article-title":"Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy","volume":"9","author":"Webb TR","year":"2009","unstructured":"Webb TR, Slavish J, George RE, et al.. Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy. Expert Rev Anticancer Ther. 2009, 9:331-56. 10.1586\/14737140.9.3.331","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-310342","article-title":"Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project","volume":"117","author":"Weisenburger DD","year":"2011","unstructured":"Weisenburger DD, Savage KJ, Harris NL, et al.. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood. 2011, 117:3402-8. 10.1182\/blood-2010-09-310342","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2012.42.2345","article-title":"Prognostic factors and long term outcome of 138 adults with systemic anaplastic large-cell lymphoma: a retrospective study by the Groupe d'Etude Des Lymphomes De l'Adulte (GELA)","volume":"116","author":"Sibon D","year":"2012","unstructured":"Sibon D, Fournier M, Briere J, et al.. Prognostic factors and long term outcome of 138 adults with systemic anaplastic large-cell lymphoma: a retrospective study by the Groupe d'Etude Des Lymphomes De l'Adulte (GELA). Blood. 2012, 116:322. 10.1200\/jco.2012.42.2345","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13184667","article-title":"ALK-negative anaplastic large cell lymphoma: current concepts and molecular pathogenesis of a heterogeneous group of large T-cell lymphomas","volume":"13","author":"Pina-Oviedo S","year":"2021","unstructured":"Pina-Oviedo S, Ortiz-Hidalgo C, Carballo-Zarate AA, Zarate-Osorno A. ALK-negative anaplastic large cell lymphoma: current concepts and molecular pathogenesis of a heterogeneous group of large T-cell lymphomas. Cancers (Basel). 2021, 13:4667. 10.3390\/cancers13184667","journal-title":"Cancers (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0000000000000047","article-title":"Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous","volume":"22","author":"Xing X","year":"2015","unstructured":"Xing X, Feldman AL. Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous. Adv Anat Pathol. 2015, 22:29-49. 10.1097\/PAP.0000000000000047","journal-title":"Adv Anat Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.12.3681","article-title":"CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features","volume":"1","author":"Stein H","year":"2000","unstructured":"Stein H, Foss HD, D\u00fcrkop H, et al.. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood. 2000, 1:3681-95. 10.1182\/blood.V96.12.3681","journal-title":"Blood"},{"key":"ref8","article-title":"ALK Negative Anaplastic Large Cell Lymphoma","author":"Kao EY","year":"2022","unstructured":"Kao EY, Mukkamalla SKR, Lynch DT. ALK Negative Anaplastic Large Cell Lymphoma. StatPearls [Internet, Treasure Island (FL); 2022."},{"key":"ref9","article-title":"Anaplastic Large Cell Lymphoma","author":"Kaseb H","year":"2022","unstructured":"Kaseb H, Mukkamalla SKR, Rajasurya V. Anaplastic Large Cell Lymphoma. StatPearls [Internet], Treasure Island (FL); 2022."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.10.3509.422k36_3509_3515","article-title":"Lymphomas expressing ALK fusion protein(s) other than NPM-ALK","volume":"10","author":"Falini B","year":"1994","unstructured":"Falini B, Pulford K, Pucciarini A, et al.. Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood. 1994, 10:3509-15. 10.1182\/blood.V94.10.3509.422k36_3509_3515","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1309\/r2q9ccuvtlrycf3h","article-title":"Anaplastic large cell lymphoma","volume":"127","author":"Medeiros LJ","year":"2007","unstructured":"Medeiros LJ, Elenitoba-Johnson KS. Anaplastic large cell lymphoma. Am J Clin Pathol. 2007, 127:707-22. 10.1309\/r2q9ccuvtlrycf3h","journal-title":"Am J Clin Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla Castellar ER","year":"2014","unstructured":"Parrilla Castellar ER, Jaffe ES, Said JW, et al.. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. Blood. 2014, 124:1473-80. 10.1182\/blood-2014-04-571091","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.9.2993","article-title":"Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T\/null cell phenotype","volume":"96","author":"Suzuki R","year":"2000","unstructured":"Suzuki R, Kagami Y, Takeuchi K, et al.. Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T\/null cell phenotype. Blood. 2000, 96:2993-3000. 10.1182\/blood.V96.9.2993","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.2345","article-title":"Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials","volume":"30","author":"Sibon D","year":"2012","unstructured":"Sibon D, Fournier M, Bri\u00e8re J, et al.. Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials. J Clin Oncol. 2012, 30:3939-46. 10.1200\/JCO.2012.42.2345","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.12.4540","article-title":"Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma","volume":"99","author":"ten Berge RL","year":"2002","unstructured":"ten Berge RL, Meijer CJ, Dukers DF, et al.. Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma. Blood. 2002, 99:4540-6. 10.1182\/blood.v99.12.4540","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/109554-primary-anaplastic-lymphoma-kinase-alk-negative-anaplastic-large-cell-lymphoma-alcl-presenting-as-perforation-peritonitis-a-case-report-and-management-principles","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:40:19Z","timestamp":1707507619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/109554-primary-anaplastic-lymphoma-kinase-alk-negative-anaplastic-large-cell-lymphoma-alcl-presenting-as-perforation-peritonitis-a-case-report-and-management-principles"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,3]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.28738","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,3]]}}}